Latest News and Press Releases

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) indberetter hermed følgende transaktioner: 1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til dennea)NavnSøren Daniel...

Bemærk venligst, at rapporten udelukkende foreligger på engelsk. On track for double-digit growth (unaudited) ALK’s strategy continued to deliver positive results during Q3, with broad-based...

On track for double-digit growth (unaudited) ALK’s strategy continued to deliver positive results during Q3, with broad-based growth from all regions. Tablet sales grew by 35% and the portfolio was...

ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that Steen Riisgaard, ALK’s Chairman of the Board, has informed the Board of Directors of his intention to step down at the company's next...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddelte i dag, at bestyrelsesformand Steen Riisgaard har meddelt bestyrelsen, at han ønsker at fratræde på selskabets ordinære generalforsamling i marts...

ALK’s new tree SLIT-tablet, ITULAZAX®, has been launched in its first market: GermanyTree pollen allergy is highly prevalent in northern Europe, making Germany a key market for the productIn trials,...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) indberetter hermed følgende transaktioner: 1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til dennea)NavnHenrik...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions: 1.Details of the person discharging managerial responsibility / person closely associateda)NameHenrik...

Bemærk venligst, at rapporten udelukkende findes på engelsk. Upgraded financial outlook and on track to deliver double-digit growth (unaudited)In Q2, ALK continued to deliver on its strategy, with...

Upgraded financial outlook and on track to deliver double-digit growth (unaudited) In Q2, ALK continued to deliver on its strategy, with broad-based growth across all regions and further strong...